Specialised pharmaceutical firm Alliance Pharma has told shareholders it is continuing to look for acquisition targets on which to spend some of its £20m-plus war chest. The Chippenham-based firm, which buys underperforming drugs brands and realises their potential through investment, has an acquisition bank facility of more than £20m. In January it acquired thyroid...